SCHEMBL33525283

SCHEMBL33525283

Cc1ccc2oc(Nc3ccc(N)cc3)nc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IL6 P05231 1/20 0.65
STAT3 P40763 1/20 0.65
MAPT P10636 6/20 0.61
RAB9A P51151 4/20 0.61
NPC1 O15118 2/20 0.61
HDAC6 Q9UBN7 2/20 0.57
ROCK1 Q13464 1/20 0.55
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 3/20 0.51
MEN1 O00255 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
AGTR1 P30556 1/20 0.49
OPRK1 P41145 1/20 0.49
KDM4E B2RXH2 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33525260 0.88 NPC1 (0.55) IL6STAT3MAPTRAB9ANPC1
SCHEMBL25788987 0.88 NPC1 (0.55) IL6STAT3MAPTRAB9ANPC1
SCHEMBL1748093 0.85 MAPT (0.61) IL6STAT3MAPTRAB9ANPC1
SCHEMBL14867035 0.85 MAPT (0.61) IL6STAT3MAPTRAB9ANPC1
SCHEMBL13436713 0.85 RAB9A (0.66) MAPTRAB9ANPC1HDAC6ROCK1
SCHEMBL25248374 0.82 IL6 (0.61) IL6STAT3MAPTRAB9ANPC1
SCHEMBL31532255 0.82 IL6 (0.61) IL6STAT3MAPTRAB9ANPC1
SCHEMBL33525267 0.82 IL6 (0.61) IL6STAT3MAPTRAB9ANPC1
SCHEMBL33525300 0.82 IL6 (0.61) IL6STAT3MAPTRAB9AKMT2A
SCHEMBL5784699 0.80 HDAC6 (0.53) IL6STAT3MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092043-A1 NOVEL BENZOXAZOLE DERIVATIVE COMPRISING 4-AMINO-BUTANAMIDE AND USE THEREOF EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION 2026-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092043-A1 NOVEL BENZOXAZOLE DERIVATIVE COMPRISING 4-AMINO-BUTANAMIDE AND USE THEREOF IL4I1, GABRB1, IL1B IL6 6/4885STAT3 355/4885MAPT 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.